358 related articles for article (PubMed ID: 12905144)
1. Epidemiological, clinical, and prognostic differences between the diseases caused by Mycobacterium kansasii and Mycobacterium tuberculosis in patients infected with human immunodeficiency virus: a multicenter study.
Canueto-Quintero J; Caballero-Granado FJ; Herrero-Romero M; Domínguez-Castellano A; Martín-Rico P; Verdú EV; Santamaría DS; Cerquera RC; Torres-Tortosa M;
Clin Infect Dis; 2003 Aug; 37(4):584-90. PubMed ID: 12905144
[TBL] [Abstract][Full Text] [Related]
2. [Disease caused by Mycobacterium kansasii in patients with HIV infection].
Urkijo JC; Montejo M; Aguirrebengoa K; Urra E; Aguirre C
Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):120-5. PubMed ID: 8499509
[TBL] [Abstract][Full Text] [Related]
3. [Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic].
van der Meer JT; Kerssemakers SP; van Steenwijk RP; Kuijper EJ
Ned Tijdschr Geneeskd; 1998 Apr; 142(17):965-9. PubMed ID: 9623171
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.
Santin M; Alcaide F
Int J Tuberc Lung Dis; 2003 Jul; 7(7):673-7. PubMed ID: 12870689
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary infection by Mycobacterium kansasii. Presentation of 27 cases (1988-1992)].
Echevarría MP; Martín G; Pérez J; Urkijo JC
Enferm Infecc Microbiol Clin; 1994; 12(6):280-4. PubMed ID: 8080864
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium tuberculosis bacteremia in patients with and without human immunodeficiency virus infection.
Bouza E; Díaz-López MD; Moreno S; Bernaldo de Quirós JC; Vicente T; Berenguer J
Arch Intern Med; 1993 Feb; 153(4):496-500. PubMed ID: 8435029
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison.
Martín V; Caylà JA; Bolea A; Castilla J
Int J Tuberc Lung Dis; 2000 Jan; 4(1):41-6. PubMed ID: 10654643
[TBL] [Abstract][Full Text] [Related]
8. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
Marras TK; Morris A; Gonzalez LC; Daley CL
Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterial bacteraemia in patients infected and not infected with human immunodeficiency virus, Taiwan.
Tan CK; Lai CC; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
Clin Microbiol Infect; 2010 Jun; 16(6):627-30. PubMed ID: 19709128
[TBL] [Abstract][Full Text] [Related]
10. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
Li J; Munsiff SS; Driver CR; Sackoff J
Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study.
Manfredi R; Nanetti A; Valentini R; Ferri M; Morelli S; Calza L
HIV Med; 2004 Nov; 5(6):431-6. PubMed ID: 15544696
[TBL] [Abstract][Full Text] [Related]
12. [Bacteremia due to Mycobacterium tuberculosis in patients coinfected with the human immunodeficiency virus].
Dronda F; Chaves F; González López A; Catalán S; Fernández González F
Med Clin (Barc); 1993 Oct; 101(14):534-7. PubMed ID: 8231398
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
Tompkins JC; Witzig RS
Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of non-tuberculous pulmonary mycobacteriosis].
Sakatani M; Nakajima Y
Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
[TBL] [Abstract][Full Text] [Related]
15. [Specific bronchial sites of Mycobacterium kansasii in 2 patients with human immunodeficiency virus infection].
Boudon P; Lepennec MP; Malbec D; Mathieu M; Choudat L; Valeyre D
Ann Med Interne (Paris); 1997; 148(8):577-8. PubMed ID: 9538404
[No Abstract] [Full Text] [Related]
16. Characterization of mycobacteria in HIV/AIDS patients of Nepal.
Dhungana GP; Ghimire P; Sharma S; Rijal BP
JNMA J Nepal Med Assoc; 2008; 47(169):18-23. PubMed ID: 18552887
[TBL] [Abstract][Full Text] [Related]
17. Danish bacille Calmette-Guérin vaccine-induced disease in human immunodeficiency virus-infected children.
Hesseling AC; Schaaf HS; Hanekom WA; Beyers N; Cotton MF; Gie RP; Marais BJ; van Helden P; Warren RM
Clin Infect Dis; 2003 Nov; 37(9):1226-33. PubMed ID: 14557968
[TBL] [Abstract][Full Text] [Related]
18. The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners.
Corbett EL; Churchyard GJ; Hay M; Herselman P; Clayton T; Williams B; Hayes R; Mulder D; De Cock KM
Am J Respir Crit Care Med; 1999 Jul; 160(1):10-4. PubMed ID: 10390373
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium kansasii causing carpal tunnel syndrome with concomitant pulmonary Mycobacterium tuberculosis infection.
Blue ML; Payne WG; Mannari RI; Moffitt MR; Walusimbi MG; Robson MC
South Med J; 2002 Sep; 95(9):1095-8. PubMed ID: 12356122
[TBL] [Abstract][Full Text] [Related]
20. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
